Skip to content

Pilot study suggests that Kaletra maintenance therapy safe

Small number of UK HIV-positive patients at risk of exhausting treatment options

'Dear Dr' letter issued about risks of using tenofovir and ddI together

Tipranavir superior to other PIs in detailed resistance analysis

Little difference in child transmission rates between formula feed and breast-plus-AZT

Highly sensitive method uncovers high levels of resistance in mothers given single-dose nevirapine

The ‘New York case’: details revealed at Boston conference

Viral load blips are likely due to lab error and not cause for concern

Commentary: How important is the New York resistance case?